Publication | Closed Access

Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells

Breast OncologyHmg-coa ReductaseMedicineMolecular MechanismCell DeathAnti-cancer ActivityBreast CancerAnti-cancer AgentPharmacologyCell BiologyTumor Microenvironment